Jamil Syed

903 citations
50 papers · 601 indexed · h-index 14
Topics
Renal cell carcinoma treatment (16 papers)Prostate Cancer Diagnosis and Treatment (14 papers)Prostate Cancer Treatment and Research (12 papers)
Partner nations
United StatesChinaCanada

In The Last Decade

Jamil Syed

50 papers receiving 598 citations

Peers

Jamil Syed
Comparison fields: 5 of 66
  • Pulmonary and Respiratory Medicine 475
  • Molecular Biology 144
  • Rheumatology 102
  • Radiology, Nuclear Medicine and Imaging 100
  • Oncology 80
Replace Hsiao‐Jen Chung with:
Hsiao‐Jen Chung Taiwan
Dominique Rossi France
Han J.A. Mensink Netherlands
Mitsuhiro Tambo Japan
J.M. Abascal Junquera Spain
Peter Weibl Austria
Sebastian Frees Germany
J Guiter France
Karl Leeb Austria
Koji Mita Japan
Jamil Syed relative to Hsiao‐Jen Chung Taiwan Hsiao‐Jen Chung's profile →
Citations per field
00.5×2.5×
Hsiao‐Jen Chung · 1×
Citations per year

Countries citing papers authored by Jamil Syed

Since Specialization
Citations

This map shows the geographic impact of Jamil Syed's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jamil Syed with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jamil Syed more than expected).

Fields of papers citing papers by Jamil Syed

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jamil Syed. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jamil Syed. The network helps show where Jamil Syed may publish in the future.

Co-authorship network of co-authors of Jamil Syed

This figure shows the co-authorship network connecting the top 25 collaborators of Jamil Syed. A scholar is included among the top collaborators of Jamil Syed based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jamil Syed. Jamil Syed is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 5
3 1
4 1
5 4
6 6
7 1
8 1
9 14
10 7
11 59
12 31
13 10
14 9
15 13
16 16
17 5
18 21
19 12
20 40

About Jamil Syed

Jamil Syed is a scholar working on Pulmonary and Respiratory Medicine, Internal Medicine and Transplantation, having authored 50 papers that have together received 601 indexed citations. Recurring topics across this work include Renal cell carcinoma treatment (16 papers), Prostate Cancer Diagnosis and Treatment (14 papers) and Prostate Cancer Treatment and Research (12 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (475 citations), Rheumatology (102 citations) and Cancer Research (66 citations). Jamil Syed has collaborated with scholars based in United States, China and Canada. Frequent co-authors include Kevin A. Nguyen, Brian Shuch, Michael Leapman, Preston Sprenkle, Kamyar Ghabili, Walter Hsiang, Jeffrey C. Weinreb, Erin Hofstatter, Michael Spektor and Karina L. Brierley. Their work appears in journals such as Journal of Clinical Oncology, Cancer and Clinical Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026